
Low-cost California-made Insulin Promised in 2024 Still Not Available
Two years ago, California made a bold announcement that it would manufacture a state-branded, low-cost insulin. Drug manufacturers, insurers, economists and diabetics took notice. It had the potential to disrupt the market, bring down drug costs and save …